ADDF Statement On FDA's Traditional Approval of Lecanemab (L

ADDF Statement On FDA's Traditional Approval of Lecanemab (Leqembi)

/PRNewswire/ -- Today's FDA approval of the monoclonal antibody lecanemab (Leqembi) for the treatment of patients with mild cognitive impairment or early stage...

Related Keywords

Ronalds Lauder , Howard Fillit , Therini Bio , Alzheimer Drug Discovery Foundation , Chief Science Officer , Drug Discovery Foundation , Drug Discovery , Alzheimer 39s Drug Discovery Foundation ,